CONMED Corporation

CNMD | NYSE

Price Alert Chart Builder DCF Calculator

$45.98

+$1.29 (+2.89%)

Sep 22, 2026, 1:58 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

+2.89%

(1D)

Rating

Updated: Aug 29, 2026

57.1

Fundamentals Strong

Market Sentiment Bullish

Moat Narrow

Full Analysis

Key Statistics

Market Data

Market Cap $1.38B

1D Range

45.27 45.98

52W Range

31.44 53.66

Valuation (TTM)

PE 24.16

PB 1.29

EV/EBITDA 11.86

Valuation (NTM)

Forward PE 9.03

Forward PEG 4.45

Price Target $37.50

Cash Flow

FCF Yield 10.1%

SBC Adj. FCF Yield 8.5%

SBC Impact -15.1%

Margins

Gross Margin 54.8%

Operating Margin 10.8%

FCF Margin 9.8%

Growth (CAGR)

Revenue 3Y | 5Y 6.4% | 7.0%

Dil EPS 3Y | 5Y -13.2% | 1.0%

FCF 3Y | 5Y 103.5% | 6.2%

Returns

ROA 2.5%

ROE 5.5%

ROIC 5.0%

Financial Health

Net Debt

$796.92M

Current Ratio 1.48

Interest Coverage 4.95

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

CONMED Corporation functions as a medical technology enterprise, specializing in the global development, production, and distribution of surgical instruments and related apparatus for a variety of sur...

Sector Healthcare

Industry Medical - Devices

Employees 3,900

IPO Date Jul 22, 1987

Website www.conmed.com

Fiscal Year January - December

Full Company Profile

Latest News

6 days ago · zacks.com

Here's Why You Should Retain CONMED Stock in Your Portfolio for Now

CONMED's BioBrace and AirSeal platforms, robotic growth and easing supply bottlenecks support its long-term outlook despite tariff headwinds.

25 days ago · zacks.com

Conmed (CNMD) Up 7.1% Since Last Earnings Report: Can It Continue?

Conmed (CNMD) reported earnings 30 days ago. What's next for the stock?

27 days ago · businesswire.com

CONMED Corporation to Participate in the Wells Fargo 21st Annual Healthcare Conference

LARGO, Fla.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) today announced its participation in the Wells Fargo 21st Annual Healthcare Conference, which is being held September 8-10, 2026 at the Encore Boston Harbor in Everett, MA. Management will participate in a fireside chat on Wednesday, September 9th at 1:30 p.m. Eastern Time. A live audio webcast of the fireside chat will be accessible under the “Events” section of the company's investor relations website: https://www.conmed.com/en/inv.

1 month ago · seekingalpha.com

CONMED Corporation: Organic Growth Is Masked By Divestitures

Conmed's headline growth appeared flat at $343 million in the last quarter, but organic growth actually increased by 6%, with the leading segment being the orthopedic surgery business. Growth was offset by the divestiture of the GI business; as a result, growth metrics look poor with a quant rating of F and below the sector growth. When I adjust for organic growth, impressive profitability, and a buyback story, Conmed stock looks highly undervalued below the sector multiple. and I am rating it a buy.